TRENTON, N.J. -- (AP) The roller coaster ride for Merck & Co. shareholders and employees is on another speedy downhill run.  In barely a week, Merck has suffered a stunning streak of setbacks, including federal regulators rejecting two experimental drugs and publicly demanding the drugmaker clean up significant problems at its main vaccine plant.  Full version available to lexis.com subscribers.